These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Bioelectrical impedance vector analysis as a useful predictor of nutritional status in patients with short bowel syndrome. Author: Fassini PG, Nicoletti CF, Pfrimer K, Nonino CB, Marchini JS, Ferriolli E. Journal: Clin Nutr; 2017 Aug; 36(4):1117-1121. PubMed ID: 27491548. Abstract: BACKGROUND & AIMS: Short bowel syndrome (SBS) represents a serious intestinal absorption disorder. Therefore, patients with SBS may have severe malnutrition and excessive mineral and fluid losses. Once the assessment of nutritional status is important in their follow-up, body composition measurements and especially total body water (TBW) must be repeatedly evaluated for the assessment of changes in hydration and nutritional care. The aim of this study was to investigate if bioelectrical impedance vector analysis (BIVA) is a useful predictor of nutritional and hydration status in SBS patients. METHODS: In this observational study, 22 participants (12 women), 11 with SBS and 11 gender, age and BMI-matched controls, were evaluated using the bioelectrical impedance measurements (BIA) and BIVA to assess nutritional and hydration status. RESULTS: Participants age was 53 ± 8 y (mean ± SD). Body water, fat mass and lean mass as assessed by BIA did not differ between the two groups. However, BIVA showed important differences between the groups regarding hydration and amount of soft tissue (p < 0.0001 for women and p = 0.0015 for men). The results also evidenced that women's vectors were related to cachexia, while men's vectors were divided into lean and cachexia quadrants. The use of BIVA analysis also evidenced hydration disturbance and losses of soft tissue. CONCLUSIONS: BIVA may represent a better predictor of nutritional status for analysis and interpretation of body composition in patients with short bowel syndrome. This trial was registered at ClinicalTrials.gov as NCT02113228.[Abstract] [Full Text] [Related] [New Search]